CASP3 and neoplasm: As shown in Figures 6A,B, the immunohistochemistry results revealed that, compared with the control and single-drug treatment groups, the combined drug treatment group exhibited a significantly larger area of positive staining for Cl-Caspase 3 and GSDME-N proteins in the tumor tissues.